Navigation Links
Arena Pharmaceuticals to Present at Upcoming Investor Conferences
Date:8/30/2012

SAN DIEGO, Aug. 30, 2012 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the company is scheduled to present corporate updates at the following three upcoming investor conferences:

  • Stifel Nicolaus Healthcare Conference
    Presentation: September 6, 2012, at 9:10 a.m. Eastern Time (6:10 a.m. Pacific Time) at the Four Seasons Hotel in Boston, Massachusetts
    Presenting: Robert E. Hoffman, Senior Vice President, Finance and Chief Financial Officer 
  • NewsMakers in the Biotech Industry
    Presentation: September 7, 2012, at 10:30 a.m. Eastern Time (7:30 a.m. Pacific Time) at the Millennium Broadway Hotel in New York, New York
    Presenting: Craig M. Audet, Senior Vice President, Operations and Head of Global Regulatory Affairs
  • Bank of America Merrill Lynch Global Healthcare Conference
    Presentation: September 12, 2012, at 8:55 a.m. British Summer Time (12:55 a.m. Pacific Time) at the Bank of America Merrill Lynch Financial Centre in London, England
    Presenting: Dominic P. Behan, Ph.D., Executive Vice President and Chief Scientific Officer 
  • Arena's presentations at these conferences will be webcast live. Each of the audio webcasts will be available under the investor relations section of Arena's website at www.arenapharm.com, and will be archived there for 30 days following the presentation. Please connect to Arena's website several minutes prior to the start of each webcast to ensure adequate time for any software download that may be necessary. 

    Arena also announced today that it is scheduled to participate in panel presentations at Citi's 7th Annual Biotech Day on September 5, 2012, at the Mandarin Oriental Hotel in Boston, Massachusetts and at the Rodman and Renshaw Global Investment Conference on September 10, 2012, at The Waldorf Astoria Ho
    '/>"/>

    SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. Arena Pharmaceuticals Announces First Quarter 2012 Financial Results and Recent Developments
    2. Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock
    3. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
    4. Aperture Health, Inc., Targeting the Strong Growth in the Long Term Disease Management arena
    5. Arena Pharmaceuticals Promotes Craig M. Audet to Executive Officer as Senior Vice President, Operations and Head of Global Regulatory Affairs
    6. Arena Pharmaceuticals to Present at the Seventh Annual JMP Securities Healthcare Conference
    7. Arena Pharmaceuticals Files Marketing Authorization Application in Switzerland for Lorcaserin as a Treatment for Weight Control
    8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Thursday, August 9
    9. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
    10. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
    11. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/30/2014)... This study provides an analysis of ... including nuclear imaging informatics, PET imaging informatics, and ... the size of the market based on its ... future growth based on the current drivers and ... in the broader markets for imaging equipment, advanced ...
    (Date:9/30/2014)... Aileron Therapeutics, Inc. - Product Pipeline ... Direct,s, ,Aileron Therapeutics, Inc. - Product Pipeline Review ... Therapeutics, Inc.,s pharmaceutical research and development focus. ... therapeutic developmental pipeline of Aileron Therapeutics, Inc.,s, complete ... by drug target, mechanism of action (MoA), route ...
    (Date:9/30/2014)... 30, 2014  According to their CEO, ... clinical trials is going through a complete transformation ... work of the current clinical trial management process ... generation, clinical trials, which will ultimately drive the ... The company has been recognized by the National ...
    Breaking Medicine Technology:Analysis of the US Molecular Imaging Informatics Market 2Analysis of the US Molecular Imaging Informatics Market 3Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 3Small Denver Company Pharmatech driving a large revolution in how cancer clinical trials are managed 2
    ... is pleased to introduce the GlideScope(®) Cobalt AVL, an ... clarity, enabling quick intubation. The new single use ... offers integrated real-time recording as well as advanced resolution ... to the GlideScope(®) brand also provides a unique on-board ...
    ... YORK, Oct. 15 This year,s American Friends of ... shaping up to be an unforgettable evening. With Larry ... gala is being held on the historic Intrepid Sea, Air ... people will be in attendance, including diplomats, civic, business, medical ...
    Cached Medicine Technology:Verathon Introduces the GlideScope(R) Cobalt Advanced Video Laryngoscope (AVL); New Digital Technology Facilitates Quick Intubations 2Larry King to Host 10th Annual American Friends of Rabin Medical Center 'Broadway on the Hudson' Gala 2Larry King to Host 10th Annual American Friends of Rabin Medical Center 'Broadway on the Hudson' Gala 3
    (Date:9/30/2014)... the spiraling costs of drugs paid for by the ... meaningful impact on cancer chemotherapy drug costs, say a ... Oncology published online today. , "We looked at ... cancers, and did not find a substantial change in ... the recent Medicare law in 2005," says the study,s ...
    (Date:9/30/2014)... Centers (FQHCs) granted new patient appointments to Medicaid ... other primary care practices (non-FQHCs), in addition to ... a new 10-state University of Pennsylvania study published ... Using data from a previous "secret shopper" study ... that FQHCs community health clinics that receive ...
    (Date:9/30/2014)... 2014 Glycodrive , one of ... to help maximize lean, strong muscle growth with a ... of glucose has caught the attention of Shane Michaels, ... behind Glycodrive is to help the body use carbohydrates ... “Carbs are essential in the muscle-building process, and Glycodrive ...
    (Date:9/30/2014)... 30, 2014 The American Diabetes ... help diabetics curb their sweet tooth, but the most ... this September, suggests that zero-calorie sweeteners may actually be ... , The Weizmann Institute of Science in Israel ... sweeteners to mice, the mice developed glucose intolerance. They ...
    (Date:9/30/2014)... September 30, 2014 With the ... strains emerging every day, it’s a perfect time ... The EnviroShield system is an electro-static disinfectant delivery ... to surface normally missed with spray-on disinfectant applicators. ... that adds an electrostatic negative charge to the ...
    Breaking Medicine News(10 mins):Health News:Landmark Medicare law had little impact on reducing chemotherapy cost 2Health News:Medicaid and Uninsured patients obtain new patient appointments most easily at FQHCs 2Health News:Glycodrive Review Exposes Blue Star Nutraceutical’s Supplement for Leaner, Stronger Muscles 2Health News:Artificial Sweeteners May be Linked to Greater Diabetes Risk 2Health News:Columbus Janitorial Company Announces New Disinfecting System for your workplace 2
    ... (NEWARK, N.J., March 18, 2008) Julia Duane Quinlan, ... remove her daughter from a respirator changed the use ... annual Joe and Julia Quinlan Award to Dr. John ... Rev. Charles J. Hudson and Margaret J. Coloney from ...
    ... than 30% Enrolled in Consumer-Driven Plans Have Household ... Enrollment in,consumer-driven and high-deductible health plans increased ... of the overall insurance market, according,to the third ... Enrollment in consumer-driven plans with a tax-advantaged,account was ...
    ... Inc. (NYSE: BRL ), today confirmed that ... Deutsche Bank, acting as PLIVA,s GDR,Depositary, on termination ... June 19, 2008 ("Termination Date"). Once the Deposit,Agreement ... from the London,Stock Exchange ("LSE"), a process that ...
    ... Internal Controls and Procedures Improvements, Corporate, Governance Enhancements, ... Va., March 18 Sunrise Senior Living,Inc. (NYSE: ... New York Stock,Exchange ("NYSE") that the Company did not ... filing its 2006 Form 10-K. The Company also,announced the ...
    ... severe inherited metabolic disorder, which is associated with ... cardiac manifestations in Wilson,s disease include arrhythmias and ... Ihtisas Hospital and in Ankara University Faculty of ... non-invasive marker of intra-atrial conduction disturbance in patients ...
    ... who experience military combat obviously endure extreme stress, and ... of post-traumatic stress disorder, or PTSD. PTSD is ... However, as researcher Roger Pitman explains, Although it ... by the traumatic event, it is also possible that ...
    Cached Medicine News:Health News:Julia Quinlan to present awards at a conference hosted by Rutgers College of Nursing 2Health News:New EBRI/Commonwealth Fund Research: Enrollment in Consumer-Driven Plans Remains Low, Survey Shows 2Health News:New EBRI/Commonwealth Fund Research: Enrollment in Consumer-Driven Plans Remains Low, Survey Shows 3Health News:New EBRI/Commonwealth Fund Research: Enrollment in Consumer-Driven Plans Remains Low, Survey Shows 4Health News:Barr's PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange 2Health News:Barr's PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange 3Health News:Barr's PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange 4Health News:Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K 2Health News:Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K 3Health News:Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K 4Health News:Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K 5Health News:Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K 6Health News:Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K 7Health News:Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K 8Health News:Sunrise Misses NYSE Deadline for Filing 2006 Form 10-K 9Health News:How does P wave dispersion change in patients with Wilson's disease? 2Health News:Does stress damage the brain? 2
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: